The University of Chicago Header Logo

Connection

Caner Saygin to Myeloproliferative Disorders

Back to Details
This is a "connection" page, showing publications Caner Saygin has written about Myeloproliferative Disorders.
Caner Saygin
Connection Strength
0.050
Myeloproliferative Disorders
  1. Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leuk Lymphoma. 2024 Jun; 65(6):864-867.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.